Company / Interest Expense
Emergent BioSolutions Inc. Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$87.9M
FY2023
5-year range
$34.5M / $87.9M
FY2019-FY2023
Trend
+135.7%
vs FY2022
Sector context
#10 of 44
Health Care
What the data says
Emergent BioSolutions Inc.'s interest expense of $88M is higher than 77% of companies in the Health Care sector (FY2023). Interest Expense has increased for 3 consecutive years, from $31M in FY2020 to $88M in FY2023.
Based on SEC 10-K filings.
$88M in FY2023 with a 5-year CAGR of +63.2%. Top quartile in the Health Care sector.
Increased from $35M to $88M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +41.1%
- 5-Year CAGR
- +63.2%
- 10-Year CAGR
- -
Sector benchmark
-69.8% below sector average
Key checks
Key Insights
- Emergent BioSolutions Inc.'s interest expense has grown for 3 consecutive years.
- 5-year CAGR of +63.2%, indicating consistent growth.
- In FY2023, interest expense increased 135.7% year-over-year.
- Ranks #10 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $87.9M | +135.7% |
| FY2022 | $37.3M | +8.1% |
| FY2021 | $34.5M | +10.2% |
| FY2020 | $31.3M | -18.5% |
| FY2019 | $38.4M | +405.3% |
| FY2018 | $7.6M | +15.2% |
| FY2017 | $6.6M | -13.2% |
| FY2016 | $7.6M | +16.5% |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026